小结
定义
病史和体格检查
关键诊断因素
- poor sleep
- daytime impairment
- periodic limb movements (mostly legs)
其他诊断因素
- age >70 years
- re-enactment of dreams during the night
- irresistible urge to move legs, and abnormal sensations in lower limbs
- snoring
- early-morning dry mouth
- headache
- elevated body mass index
- withdrawal from benzodiazepines or barbiturates
- use of antipsychotics
- use of dopaminergic drugs
- pallor
- iron deficiency
- diabetes mellitus
- spinal cord injury
- episodes of sudden onset of sleep during the day; may or may not be associated with loss of muscle tone
危险因素
- age >70 years
- female sex
诊断性检查
首要检查
- polysomnography: electromyography (EMG) evaluation of limb movements
- polysomnography: electroencephalogram (EEG) evaluation
- polysomnography: assessment of sleep-related breathing disorders
- CBC
- serum ferritin
- BUN
需考虑的检查
- actigraphy
治疗流程
primary (idiopathic) PLMD
PLMD associated with other conditions
Colaboradores
Autores
Tim Soane, BMBS (Hons), MSci, MRCP (Edin), PhD
Neurology Registrar
Department of Clinical Neurosciences
Western General Hospital
Edinburgh
UK
Declarações
TS has been reimbursed for attending conferences by Biogen, Roche, and Novartis.
Suvankar Pal, BSc (Hons), MBBS (Dist), MRCP (UK), MD (Res), PGCME, FHEA

Consultant Neurologist and Honorary Senior Lecturer
Department of Clinical Neurosciences
Western General Hospital
Edinburgh
UK
Declarações
SP declares that he has no competing interests.
Richard Davenport, DM, FRCP Edin

Consultant Neurologist and Honorary Senior Lecturer
Department of Clinical Neurosciences
Western General Hospital
Edinburgh
UK
Declarações
RD declares that he has no competing interests.
Revisores
Paul Reading, MBBS
Consultant Neurologist
James Cook University Hospital
Middlesbrough
UK
Declarações
PR declares that he has no competing interests.
Karl Doghramji, MD
Director
Sleep Disorders Center
Thomas Jefferson University Hospital
Philadelphia
PA
Declarações
KD is a speaker for Sanofi-Aventis, King Pharmaceuticals, Takeda Pharmaceuticals, Sepracor, and Pfizer; a consultant for Sanofi-Aventis, Takeda Pharmaceuticals, Sepracor, Pfizer, and Neurocrine Biosciences; and has stock in Merck.
Kirstie Anderson, BMedSci, MBBS, MRCP, DPhil
Consultant Neurologist
Department of Neurology
Freeman Hospital
Newcastle upon Tyne
UK
Declarações
KA declares that she has no competing interests.
Créditos aos pareceristas
Os tópicos do BMJ Best Practice são constantemente atualizados, seguindo os desenvolvimentos das evidências e das diretrizes. Os pareceristas aqui listados revisaram o conteúdo pelo menos uma vez durante a história do tópico.
Declarações
As afiliações e declarações dos pareceristas referem--se ao momento da revisão.
Referências
Principais artigos
Garcia-Borreguero D, Ferini-Strambi L, Kohnen R, et al. European guidelines on management of restless legs syndrome: report of a joint task force by the European Federation of Neurological Societies, the European Neurological Society and the European Sleep Research Society. Eur J Neurol. 2012;19:1385-1396. Resumo
Ferri R, Fulda S, Allen RP, et al. World Association of Sleep Medicine (WASM) 2016 standards for recording and scoring leg movements in polysomnograms developed by a joint task force from the International and the European Restless Legs Syndrome Study Groups (IRLSSG and EURLSSG). Sleep Med. 2016 Oct;26:86-95. Resumo
Winkelman JW, Berkowski JA, DelRosso LM, et al. Treatment of restless legs syndrome and periodic limb movement disorder: an American Academy of Sleep Medicine clinical practice guideline. J Clin Sleep Med. 2025 Jan 1;21(1):137-52.Texto completo Resumo
Artigos de referência
Uma lista completa das fontes referenciadas neste tópico está disponível para os usuários com acesso total ao BMJ Best Practice.
Diagnósticos diferenciais
- Nocturnal epilepsy
- Sleep-disordered breathing
- Sleep starts
Mais Diagnósticos diferenciaisDiretrizes
- Treatment of restless legs syndrome and periodic limb movement disorder: an American Academy of Sleep Medicine clinical practice guideline
- Manual for the scoring of sleep and associated events
Mais DiretrizesFolhetos informativos para os pacientes
Insomnia
Sleep apnea in adults (obstructive)
Más Folhetos informativos para os pacientesInicie sesión o suscríbase para acceder a todo el BMJ Best Practice
El uso de este contenido está sujeto a nuestra cláusula de exención de responsabilidad